Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.870
+0.010 (0.26%)
At close: Aug 3, 2026, 4:00 PM EDT
3.875
+0.005 (0.13%)
After-hours: Aug 3, 2026, 7:34 PM EDT

Bicycle Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
61.2172.5935.2826.9814.4611.7
Revenue Growth
217.44%105.77%30.76%86.52%23.65%12.58%
Gross Profit
61.2172.5935.2826.9814.4611.7
Operating Income
-210.3-247.07-209.87-189.95-116.65-65.62
Net Income
-190.41-218.96-169.03-180.66-112.72-66.82
Earnings Per Share
-2.73-3.16-2.90-5.08-3.80-2.67
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
510.05628.11879.52526.42339.15438.68
Total Debt
13.6814.13.9940.0841.241.95
Net Cash (Debt)
496.37614.01875.53486.34297.95396.73
Net Cash Growth
-31.03%-29.87%80.02%63.23%-24.90%227.71%
Net Cash Per Share
7.148.8615.0413.6610.0515.83

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-206.05-249.68-164.72-60.63-86.11-14.79
Capital Expenditures
-2.23-2.35-1.24-2.93-18.99-2.03
Free Cash Flow
-208.28-252.03-165.96-63.56-105.1-16.82
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-343.60%-340.38%-594.96%-704.13%-806.56%-560.98%
Pretax Margin
-308.28%-301.45%-492.69%-664.32%-789.88%-585.47%
Profit Margin
-311.11%-301.66%-479.18%-669.72%-779.35%-571.25%
FCF Margin
-340.29%-347.21%-470.47%-235.61%-726.67%-143.83%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.416.7727.4128.4461.14153.93